Bethell G, Wilkinson D, Fawkner-Corbett D, Mesa A, Shukla R, Edgar D, Kenny S (2016) <br />Enteric nervous system stem cells associated with thickened extrinsic fibers in short segment aganglionic Hirschsprung's disease gut are absent in the total colonic and intestinal variants of disease<br /><i>J Pediatr Surg</i> <b>51</b>: 1581<br /><br />Atri A, Molinuevo JL, Lemming O, Wirth Y, Pulte I, Wilkinson D (2013) <br />Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy<br /><i>Alzheimers Res Ther</i> <b>5</b>: 6<br /><br />Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P (2012) <br />Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial<br /><i>J Alzheimers Dis</i> <b>29</b>: 459<br /><br />Wilkinson D (2012) <br />A review of the effects of memantine on clinical progression in Alzheimer's disease<br /><i>Int J Geriatr Psychiatry</i> <b>27</b>: 769<br /><br />Thompson HM, Wilkins S, Battersby AH, Waite RJ, Wilkinson D (2007) <br />Modelling long-term effects of IGRs on honey bee colonies<br /><i>Pest Manag Sci</i> <b>63</b>: 1081<br /><br />Burns A, O'Brien J, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D (2006) <br />Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology<br /><i>J Psychopharmacol</i> <b>20</b>: 732<br /><br />Thompson HM, Wilkins S, Battersby AH, Waite RJ, Wilkinson D (2005) <br />The effects of four insect growth-regulating (IGR) insecticides on honeybee (Apis mellifera L.) colony development, queen rearing and drone sperm production<br /><i>Ecotoxicology</i> <b>14</b>: 757<br /><br />Holmes C, Burns A, Passmore P, Forsyth D, Wilkinson D (2004) <br />AD2000: design and conclusions<br /><i>Lancet</i> <b>364</b>: 1213<br /><br />Jackson S, Ham RJ, Wilkinson D (2004) <br />The safety and tolerability of donepezil in patients with Alzheimer's disease<br /><i>British Journal of Clinical Pharmacology</i> <b>58 Suppl 1</b>: 1<br /><br />Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, Butler S, Wilkinson D, Woolford J, Waite J, McKeith IG (2001) <br />Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial<br /><i>Int Psychogeriatr</i> <b>13</b>: 199<br /><br />Wilkinson D, Murray J (2001) <br />Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease<br /><i>Int J Geriatr Psychiatry</i> <b>16</b>: 852<br /><br />Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, Schneider L, Takeda M, Tariot P, Wilkinson D (2001) <br />Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?<br /><i>Int J Geriatr Psychiatry</i> <b>16</b>: 653<br /><br />McKeith IG, Grace JB, Walker Z, Byrne EJ, Wilkinson D, Stevens T, Perry EK (2000) <br />Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial<br /><i>Int J Geriatr Psychiatry</i> <b>15</b>: 387<br /><br />Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF, Dubois B (2000) <br />The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial<br /><i>J Am Geriatr Soc</i> <b>48</b>: 268<br /><br />Wilkinson D (1998) <br />Clinical experience with Donepezil (Aricept) in the UK<br /><i>J Neural Transm Suppl</i> <b>54</b>: 311<br /><br />Wilkinson D (1997) <br />Advertisements for donepezil. Review of drug in Drug and Therapeutics Bulletin is uninformed<br /><i>BMJ</i> <b>315</b>: 1625<br /><br />